Evidence map›Paper›PMID 42514876›Full record

ArticlePharmaceutics2026

Leciplex Nanocarriers: An Optimized Platform for Thymol Delivery in Acne Management.

Soha Elsalhy, Norhan Tantawy, Eman E El Naggar, Wesam E Gawad, Amira M Badr, Reem T Atawia, Jihad Mahmoud Alsofany

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soha ElsalhyDepartment of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza 12585, Egypt.ORCID 0000-0002-3312-8540
Norhan TantawyDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Capital University, Formerly Helwan University, Cairo P.O. Box 11795, Egypt.
Eman E El NaggarDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Horus University, New Damietta 34518, Egypt.
Wesam E GawadDepartment of Microbiology and Immunology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City 12566, Egypt.ORCID 0000-0002-6028-8881
Amira M BadrDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11415, Saudi Arabia.ORCID 0000-0003-3983-868X
Reem T AtawiaDepartment of Pharmaceutical Sciences, College of Pharmacy, Southwestern Oklahoma State University, Weatherford, OK 73096, USA.
Jihad Mahmoud AlsofanyDepartment of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Menoufia, Egypt.ORCID 0000-0002-0006-443X

Funding

King Saud University ORF-2026-1710
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acne vulagrisI-optimal designLeciplexnano-carrierthymol

Identifiers

PMID42514876
PMCPMC13414981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.